Does USTEKINUMAB Cause Epilepsy? 512 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 512 reports of Epilepsy have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.6% of all adverse event reports for USTEKINUMAB.
512
Reports of Epilepsy with USTEKINUMAB
0.6%
of all USTEKINUMAB reports
424
Deaths
410
Hospitalizations
How Dangerous Is Epilepsy From USTEKINUMAB?
Of the 512 reports, 424 (82.8%) resulted in death, 410 (80.1%) required hospitalization, and 415 (81.1%) were considered life-threatening.
Is Epilepsy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 512 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Epilepsy?
LEVETIRACETAM (2,546)
LAMOTRIGINE (1,758)
ADALIMUMAB (1,107)
TOPIRAMATE (1,066)
METHOTREXATE (960)
LACOSAMIDE (902)
VALPROATE (878)
CARBAMAZEPINE (869)
RITUXIMAB (846)
CETIRIZINE (837)
Which USTEKINUMAB Alternatives Have Lower Epilepsy Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE